Program for Recovery of Continence, Sexual Function, and Fitness in Men After Prostate Cancer Surgery
A Study of Combined Pelvic Health Rehabilitation and Exercise
Led by University of Alberta · Updated on 2026-08-12
106
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate recovery of continence, sexual function, and overall health outcomes in men who have undergone prostatectomy surgery for prostate cancer. The study focuses on understanding the timelines for recovery and assessing physical activity, fitness, and quality of life after surgery. The study also investigates a combined pelvic health rehabilitation and exercise program delivered both in-person and virtually to support equitable access.
Participants will be randomly assigned to one of two groups one receiving a pelvic floor exercise program combined with general exercise programming, and the other receiving pelvic floor exercises alongside standard physical activity counseling. The program includes online education about continence and sexual health, a group fitness exercise program tailored for early post-surgery recovery, and intensive pelvic floor muscle training. The intervention lasts 12 weeks, with continued monitoring up to one year.
Participants will be assessed through questionnaires, physical fitness tests, and metabolic health measurements at multiple time points including immediately after surgery, 12 weeks, and one year. Researchers will track adherence to the program and evaluate outcomes such as urinary continence, sexual function, symptom burden, and cardiometabolic indicators. Safety and progress will be monitored regularly throughout the study duration, which extends up to one year after surgery.
CONDITIONS
Brief Title
Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer
Research Team
M
Margaret L McNeely
C
Chris Sellar
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Have a diagnosis of prostate cancer (stage I to IV)
Are scheduled for prostatectomy surgery (any surgical approach)
Are able to participate in at least mild physical activity as confirmed by the Physical Activity Readiness Questionnaire (PAR-Q+)
Speak and understand English
Are 18 years of age or older
Willing and able to commit to the 12-week exercise intervention (optional)
You will not qualify if you...
Have medical conditions that may interfere with continence, such as neurological diseases
Have contraindications to exercise testing or training
Have had recent (within 6 months) changes to medications aimed at reducing urinary incontinence
Do not have regular access to the internet and a smart device or computer at home or community center
Are already receiving a pelvic floor exercise program from a community pelvic floor physical therapist
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Intervention
Duration - 12 weeks
Participants receive either a combined pelvic floor and general exercise program or pelvic floor exercises with physical activity counseling, delivered both in-person and virtually to support recovery after surgery.
Weekly or regular group exercise sessions and pelvic floor muscle retraining
Follow-up
Duration - Up to 1 year after surgery
Participants are assessed for urinary continence, sexual function, fitness, and metabolic health at 12 weeks and one year after surgery to evaluate recovery and program effects.
Assessments at 12 weeks and 1 year
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Study of 177Lu-PSMA as an Additional Treatment for Adult Men With High or Very High Risk Prostate Cancer After Radiation and Hormone Therapy
Phase 1b Study of 177Lu-PSMA-617 With Liver-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Phase III Study of 18F-PSMA-1007 PETCT Imaging in Adult Men with Prostate Cancer Including Post-Treatment and High-Risk Cases
Combining One MR-Guided HDR Brachytherapy and One SABR Treatment
for Favorable Risk Prostate Cancer
in a Phase 23 Study
Study of 4-Aminopyridine to Improve Nerve Recovery After Robot-Assisted Radical Prostatectomy in Men with Prostate Cancer
Phase III Study of 64Cu-GRIP B PET Imaging for Detecting Granzyme B in Adults with Advanced Genitourinary and Other Solid Tumors
Comparison of 68Ga-P16-093 and 68Ga-PSMA-11 PETCT Scans for Detecting Primary Prostate Cancer in Men
Using 68Ga-PSMA PETMRI and mpMRI to Detect Prostate Cancer in Men Aged 40 to 85
Observational Study to Compare Diagnostic Accuracy and Follow-Up Outcomes
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Noninvasive PETCT Imaging Using 68Ga-XACP3 Compared to 68Ga-PSMA in Adults With Prostate Cancer
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Control4Life: A randomized controlled trial protocol examining the feasibility and efficacy of a combined pelvic health rehabilitation and exercise fitness program for individuals undergoing prostatectomy.